R&D Systems™ Recombinant Human BCMA/TNFRSF17 Protein, Atto 488 Conjugate

Catalog No.	Quantity
ATJ193020	20 μg

Catalog No. ATJ193020 Supplier R&D Systems™ Supplier No. ATJ193020

Description

Fc Chimera

Measured by flow cytometry for its ability to bind anti-Human BCMA Monoclonal Antibody conjugated fluorescent beads.

Specifications

• Accession Number: Q6PE46
• For Use With (Application): Bioactivity
• Formulation: Supplied as a 0.2 μm filtered solution in PBS with BSA as a carrier protein.
• Gene ID (Entrez): 608
• Molecular Weight (g/mol): M.W.-observed: 35-45 kDa, under reducing conditions, M.W.-theoretical: 32 kDa (monomer)
• Quantity: 20 μg
• Source: Mouse myeloma cell line, NS0-derived human BCMA/TNFRSF17 protein Human BCMA/TNFRSF17 (Met1-Ala54) (N-terminus) Accession # Q6PE46 IEGRMD Human IgG1 (Pro100-Lys330) (C-terminus)
• Storage Requirements: Protect from light. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 6 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after opening. 3 months, -20°C to -70°C under sterile conditions after opening.
• Endotoxin Concentration: <1.0 EU / 1 μg of the protein by the LAL method.
• Gene Alias: B cell maturation antigen, B-cell maturation protein, BCMAtumor necrosis factor receptor superfamily member 17, BCMB-cell maturation factor, CD269, CD269 antigen, TNFRSF13A, TNFRSF17, tumor necrosis factor receptor superfamily, member 17
• Conjugate: Atto 488
• Purity or Quality Grade: >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining.
• Protein: BCMA/TNFRSF17